Related Experiment Video
Updated: Oct 4, 2025

09:03
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
487
Anticancer potential of allicin: A review
Elena Catanzaro1, Donatella Canistro2, Valentina Pellicioni1
1Dipartimento di Scienze per la Qualità della Vita, Alma Mater Studiorum-Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.
Pharmacological Research
|February 8, 2022
Summary
Garlic
Area of Science:
- Oncology
- Natural Products Chemistry
- Pharmacology
Background:
- Phytochemicals, including allicin from garlic, show promise in cancer research due to their biological compatibility and pharmacological effects.
- Garlic consumption is linked to health benefits, particularly in combating chronic diseases like cancer, largely due to its active compound, allicin.
- Allicin is a bioactive sulfur compound found in garlic, existing in a precursor form within the plant.
Purpose of the Study:
- To review the chemistry and biosynthesis of allicin.
- To discuss the pharmacokinetic profile, anticancer mechanisms, molecular targets, and tumor cell selectivity of allicin.
- To outline future research directions for allicin as a potential anticancer agent.
Main Methods:
- Literature review of existing research on allicin.
- Critical discussion of allicin's chemical properties and biological activities.
- Analysis of studies investigating allicin's effects on cancer pathways and tumor growth.
Main Results:
- Allicin demonstrates the ability to suppress the growth of various tumor types.
- Allicin impacts multiple signaling pathways crucial for cancer development.
- Evidence suggests allicin exhibits selectivity towards tumor cells.
Conclusions:
- Allicin is a promising natural product with significant anticancer potential.
- Further research is needed to fully elucidate allicin's therapeutic capabilities.
- Allicin's multifaceted action on cancer pathways warrants continued investigation.
Related Concept Videos
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
Cancer-Critical Genes I: Proto-oncogenes
9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Electron Transport Chain: Complex I and II
15.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Mutagenicity and Carcinogenicity
1.5K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K

